For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

A joint scientific study conducted by researchers at the Medical Research Institute of New Zealand, in collaboration with ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

Asthma is a global issue. It’s estimated that more than 334 million people around the world have asthma. It’s a chronic disease that makes it hard to breathe. Asthma often starts in childhood, but it ...

DENVER — National Jewish Health researchers are looking for ways to identify patients with untreated mild persistent asthma who might benefit from daily inhaled treatment based on inflammatory ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.

The wheezing. The coughing. The extreme and sudden shortness of breath. These are symptoms that are attached to asthma, which is a surprisingly common condition. According to the Asthma and Allergy ...

The FDA has updated the prescribing information for Airsupra, a fixed dose of albuterol and budesonide, to include that it ...

(THE CONVERSATION) Detroit kids 17 and under were nearly three times more likely to be hospitalized for asthma than other kids in Michigan, according to data from the Michigan Department of Health and ...